Information Provided By: 
Fly News Breaks for November 12, 2015
SYK, ZBH
Nov 12, 2015 | 06:23 EDT
Citi analyst Amit Hazan started shares of Zimmer Biomet (ZBH) with a Sell rating and $92 price target. The analyst expects a slowdown in orthopedics and continued uncertainty around Biomet dis-synergies in the near term. Hazan likes the Zimmer/Biomet deal longer term, however. He also started shares of Stryker (SYK) with a Sell rating.
News For ZBH;SYK From the Last 2 Days
There are no results for your query ZBH;SYK
